Cargando…
Expression of Epidermal Growth Factor Receptor Detected by Cetuximab Indicates Its Efficacy to Inhibit In Vitro and In Vivo Proliferation of Colorectal Cancer Cells
Cetuximab is a chimeric mouse–human monoclonal antibody that targets the human epidermal growth factor receptor (EGFR). However, EGFR expression determined by immunohistochemistry does not predict clinical outcomes of colorectal cancer (CRC) patients treated with cetuximab. Therefore, we evaluated t...
Autores principales: | Shigeta, Kohei, Hayashida, Tetsu, Hoshino, Yoshinori, Okabayashi, Koji, Endo, Takashi, Ishii, Yoshiyuki, Hasegawa, Hirotoshi, Kitagawa, Yuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688890/ https://www.ncbi.nlm.nih.gov/pubmed/23824671 http://dx.doi.org/10.1371/journal.pone.0066302 |
Ejemplares similares
-
The use of laparoscopic rectopexy to manage rectal prolapse with Pseudo‐Meigs’ syndrome in a 64‐year‐old female: a case report
por: Kondo, Takayuki, et al.
Publicado: (2017) -
Needlescopic versus conventional laparoscopic surgery for colorectal cancer ~a comparative study~
por: Tsuruta, Masashi, et al.
Publicado: (2018) -
Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution
por: Moritani, Konosuke, et al.
Publicado: (2013) -
The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer
por: Kondo, Takayuki, et al.
Publicado: (2016) -
Inhibition of heat shock protein 27 phosphorylation promotes sensitivity to 5-fluorouracil in colorectal cancer cells
por: MATSUNAGA, ATSUSHI, et al.
Publicado: (2014)